Tuesday August 4th 2020



Mithra, a company dedicated to Women’s Health, announces that the European Authorities have approved the extension in the shelf life of its vaginal contraceptive ring Myring™ from 24 to 36 months, allowing distributors to optimize their supply chain management.

In November 2019, Mithra announced the first approval of advantageous modifications to Myring™ labelling, extending the shelf life from 18 to 24 months, and eliminating the requirement for special storage conditions1 . Previously, Myring™ needed to be refrigerated before dispensing to the patient, at a temperature between 2 °C and 8 °C, similar to the originator product. This additional extension of the shelf life from 24 to 36 months further reduces the impact on transport and storage costs.

To date, Mithra has licensed Myring™ to industry leaders in 35 countries, including the three biggest worldwide markets. Myring™ is currently available in packages of one, three and recently six rings. The further shelf life extension to 36 months allows Mithra to consider packaging of larger quantities of rings, which would provide an even more convenient option for distributors, pharmacists and patients.

François Fornieri, CEO Mithra Women’s Health, commented: “We are very pleased that the European Authorities have approved an extended shelf life to 36 months for our contraceptive ring. In addition to the removal of the requirement for special temperature storage, and the recently available 6-pack format, this valuable shelf life extension provides Myring™ a clear advantage over competitor products.™".